Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NRG Oncology
NRG Oncology
NRG Oncology
Rigshospitalet, Denmark
Mayo Clinic
Emory University
University of California, San Diego
University of California, San Diego
Tata Memorial Centre
Dana-Farber Cancer Institute
University of Pittsburgh
Massachusetts General Hospital
AHS Cancer Control Alberta
AHS Cancer Control Alberta